论文信息 - A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway. - 字舞流文

A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway.

M. Moran | J. Li | A. Datti | Jiefei Tong | X. Mao | B. Cao | Tabitha E. Wood | R. Hurren | Xiaoming Wang | Wenjie Wang | Yueping Jin | Wenxian Sun | P. Spagnuolo | N. Maclean | J. Wrana | R. Batey | A. Schimmer | Biyin Cao | Tabitha E Wood